← Back to Patent Explorer
US4267178A Expired / Lapsed US ⏱️ 0.0 years remaining

Disubstituted piperazines

Assignee: Science Union et Cie
•
Filing: 1979-02-26
•
Granted: 1981-05-12
•
Expires: 1999-02-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disubstituted piperazines of the formula ##STR1## in which n is 1 or 2, m is 0 or 1, and Het is pyridyl, pyrimidinyl, pyrazinyl, thiazolyl or thiadiazolyl each optionally substituted by one or more alkyl having from 1 to 5 carbon atoms inclusive. These compounds and their physiologically tolerable acid addition salts thereof may be used as medicines especially in the treatment of hypertension.

Inventors

  • 👤 Gilbert Regnier
  • 👤 Michel Laubie
  • 👤 Jean-Claude Poignant

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 18:08
CPC Classifications
C; C07; C07D; C07D405/00; C07D405/14; A; A61; A61P; A61P9/00; A61P9/12

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 70 words
A compound selected from the group consisting of: disubstituted piperazines of the formula: ##STR8## in which: n is selected from 1 and 2; m is selected from 0 and 1, and Het is selected from the group consisting of pyridyl, pyrimidinyl, pyrazinyl, thiazolyl and thiadiazolyl and each of these radicals mono- and poly-substituted by alkyl having from 1 to 5 carbon atoms inclusive; and, physiologically tolerable acid addition salts thereof.
Claim 2
Dependent Claim 70 words
A compound selected from the group consisting of: disubstituted piperazines of the formula: ##STR8## in which: n is selected from 1 and 2; m is selected from 0 and 1, and Het is selected from the group consisting of pyridyl, pyrimidinyl, pyrazinyl, thiazolyl and thiadiazolyl and each of these radicals mono- and poly-substituted by alkyl having from 1 to 5 carbon atoms inclusive; and, physiologically tolerable acid addition salts thereof.
Claim 3
Dependent Claim 58 words
Compounds of claim 1, of the formula I, in which n and m have the meanings given in claim 1 and Het is selected from the group consisting of pyridyl, pyrimidinyl and thiazolyl and each of these radicals mono- and poly-substituted by alkyl having from 1 to 5 carbon atoms inclusive, and physiologically tolerable acid addition salts thereof.
Claim 4
Dependent Claim 12 words
A compound of claim 1 which is 1-(6,7-methylenedioxy-1,2,3,4-tetrahydro-2-naphtyl)-4-(2-pyrimidinyl) piperazine, and its monomethanesulfonate.
Claim 5
Dependent Claim 9 words
A compound of claim 1 which is 1-(6,7-methylenedioxy-1,2,3,4-tetrahydro-2-naphthyl)-4-(2-pyridyl) piperazine.
Claim 6
Dependent Claim 13 words
A compound of claim 1 which is 1-(6,7-methylene dioxy-1,2,3,4-tetrahydro-2-naphthyl)-4-(2-thiazolyl) piperazine, and its dihydrochloride.
Claim 7
Dependent Claim 12 words
A compound of claim 1 is 1-(5,6-methylenedioxy-2-indanyl)-4-(2-pyridyl) piperazine, and its monomethane sulfonate.
Claim 8
Dependent Claim 27 words
An antihypertensive pharmaceutical composition containing as active ingredient a compound of claim 1 in an amount of 1 to 300 mg, together with a suitable pharmaceutical carrier.
Claim 9
Dependent Claim 34 words
A method for treating a living animal body afflicted with hypertension, comprising the step of administering an amount of a compound of claim 1 which is effective for the alleviation of the said condition.

References Cited (Backward Citations)

US2543972A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-05-11 1984-11-10 1985-05-12 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-05-11 1988-11-10 1989-05-12 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-05-11 1992-11-10 1993-05-12 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag